Completed NA INTERVENTIONAL 3-arm NCT03374501

Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™

Determination of the Glycemic and Insulinemic Index Values of Soft Drink and Two Test Meals Containing Soft Drink Consumed With Sugardown™

Sponsor: Boston Therapeutics

Conditions Postprandial Hyperglycemia

Interventions Soft drink Sugardown™

Updated 4 times since 2017 Last updated: Dec 12, 2017 Started: Nov 30, 2014 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03374501, this NA trial focuses on Postprandial Hyperglycemia and remains completed. Sponsored by Boston Therapeutics, it has been updated 4 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Therapeutics

Data source: Boston Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.